SecBot SecBot
144 ·Filed May 12, 2026

PTGX

Protagonist Therapeutics, Inc
BEARISH
Impact 5/10
Horizondays Processed6mo ago SEC0001968582-26-000430
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

CEO selling $7.76M via Form 144 is a notable insider disposition. While the sale is small relative to market cap, the CEO's intent to sell a meaningful portion of his holdings (1.2% of known position) warrants monitoring. Watch for actual Form 4 filings to confirm execution and any subsequent insider buying patterns.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$103.88
T+0 close · May 12, 2026 · via day close
Latest settled
+40.42%
T+60 · $145.87
Vs SPY
+35.98%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 13 $103.88entry
  2. T+1 · 6mo ago 0.00%α +0.00% · $103.88
  3. T+5 · 6mo ago −5.30%α −4.15% · $98.37
  4. T+20 · 5mo ago +5.69%α +6.30% · $109.79
  5. T+60 · 3mo ago +40.42%α +35.98% · $145.87
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Dinesh Patel filed a Form 144 to sell 75,000 shares (~$7.76M at the filing date) via J.P. Morgan. This is a material insider sale by the CEO, representing about 1.2% of his known holdings and 0.1% of market cap. The sale follows an option exercise and comes amid strong analyst consensus (89% bullish) and a $6.7B market cap.

Key Facts

  • CEO Dinesh Patel filed Form 144 to sell 75,000 shares of common stock.
  • Approximate dollar value of proposed sale: $7,762,500.
  • Shares to be sold via J.P. Morgan Securities LLC.
  • Patel's total beneficial ownership after sale: ~64,311,373 shares.
  • Sale follows an option exercise of 75,000 shares on the same date.
  • Filing date: May 12, 2026.
  • Recent insider activity (30d): 3 sells totaling $4.4M.
  • Market cap: $6.7B; analyst consensus 89% bullish.

Financial Impact

CEO proposes to sell ~$7.76M worth of stock, ~0.12% of market cap.

dilutioninsider holdings

Risk Factors

  • Insider selling by CEO may signal lack of confidence in near-term prospects.
  • Sale is not yet executed; Form 144 is an intent to sell.
  • Option exercise suggests shares were acquired at lower cost, reducing signaling weight.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001968582-26-000430
Document: 0001968582-26-000430-index.html0001968582-26-000430
Document: 0001968582-26-000430.txt0001968582-26-000430

Track record

11 reports on PTGX

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Bullish 7/10 Entry $132.04 Now $124.83 −5.46% settles Feb 4
  2. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $143.37 Now $124.83 −12.93% settles Feb 2
  3. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $142.14 Now $124.83 −12.18% settles Jan 26
  4. Aug 10, 202614w ago 144 Bearish 5/10 Entry $148.29 to $143.37 Now $124.83 +15.82% ▲ +3.32% +2.83% vs SPY
  5. Jun 18, 202621w ago 8-K Neutral 3/10 Entry $115.03 to $143.40 Now $124.83 +8.52% ▲ +24.66% +22.92% vs SPY
  6. Jun 12, 202622w ago Institutional Cluster Mixed 5/10 Entry $109.78 to $145.94 Now $124.83 +13.71% ▲ +32.94% +29.67% vs SPY
  7. May 12, 202626w ago 144 Bearish 5/10 Viewing Entry $103.88 to $145.87 Now $124.83 −20.17% ▼ −40.42% −35.98% vs SPY
  8. May 8, 202627w ago Insider Cluster Neutral 4/10 Entry $99.36 to $135.81 Now $124.83 +25.63% ▲ +36.68% +31.85% vs SPY
  9. May 8, 202627w ago Insider Cluster Neutral 5/10 Entry $99.36 to $135.81 Now $124.83 +25.63% ▲ +36.68% +31.85% vs SPY
  10. May 5, 202627w ago 8-K Bullish 7/10 Entry $103.97 to $136.64 Now $124.83 +20.06% ▲ +31.42% +29.36% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 12, 2026